Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02343939
Title Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gilead Sciences
Indications

acute myeloid leukemia

Therapies

Decitabine

Cytarabine + Daunorubicin

Entospletinib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.